Seth H. Z. Fischer insider trades
Open-market stock purchases and sales by Seth H. Z. Fischer, Director at Esperion Therapeutics, Inc, from SEC Form 4 filings since Jan 22, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | — |
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | $28.8K |
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | $73.1K |
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | $38.3K |
| Jun 10, 2026 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
| May 28, 2026 | ESPR Esperion Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ESPR Esperion Therapeutics, Inc: other filings, last Jul 13, 2026
- MIST Milestone Pharmaceuticals Inc: other filings, last Jun 10, 2026
- MRNS Marinus Pharmaceuticals, Inc: 1 sale, last Feb 11, 2025
- AGRX Agile Therapeutics Inc: other filings, last Aug 26, 2024
- SPPI Spectrum Pharmaceuticals Inc: 2 sales, last Jul 31, 2023
- BSGM BioSig Technologies, Inc: other filings, last Oct 16, 2018
- VVUS Vivus Inc: other filings, last Jan 1, 2018